Skip to main content
Clinical Trials/NCT04985370
NCT04985370
Suspended
Not Applicable

Pain Neuroscience Education Plus Exercise Versus Exercise Alone in the Management of Chronic Rotator Cuff Tendinopathy: a Randomized Controlled Trial

Ruben Fernandez Matias1 site in 1 country52 target enrollmentJuly 25, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Rotator Cuff Tendinosis
Sponsor
Ruben Fernandez Matias
Enrollment
52
Locations
1
Primary Endpoint
Change in pain intensity
Status
Suspended
Last Updated
3 years ago

Overview

Brief Summary

The aim of this randomized controlled trial is to evaluate the combined effects of pain neuroscience education plus exercise to exercise alone in the management of patients with chronic rotator cuff tendinopathy regarding pain, function, strength, kinesiophobia, and pain catastrophizing.

Registry
clinicaltrials.gov
Start Date
July 25, 2021
End Date
October 1, 2029
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ruben Fernandez Matias
Responsible Party
Sponsor Investigator
Principal Investigator

Ruben Fernandez Matias

Clinical Professor

University of Alcala

Eligibility Criteria

Inclusion Criteria

  • Shoulder pain due to rotator cuff tendinopathy lasting more than 6 months.
  • Internal Rotation Resisted Strength Test positive.
  • Test Item Cluster (Hawkins-Kennedy, painful arc, and infraspinatus test) positive.

Exclusion Criteria

  • History of: tumors, metastasis, osteoporosis, shoulder fractures, shoulder luxation and/or instability, previous shoulder surgery, cervical radiculopathy, full-thickness rotator cuff tears, glenohumeral joint degeneration, inflammatory arthropathy, acromioclavicular joint arthrosis, and rotator cuff calcifications.
  • Being treated by other physical therapy or medical treatment for their shoulder pain at the time of recruitment.

Outcomes

Primary Outcomes

Change in pain intensity

Time Frame: Baseline, change from baseline at 4-week, and change from baseline at 12-week

Pain intensity measured with numerical pain rating scale which ranges from 0 points (no pain) to 10 points (worst imaginable pain)

Secondary Outcomes

  • Catastrophism change(Baseline, change from baseline at 4-week, and change from baseline at 12-week)
  • Shoulder disability change(Baseline, change from baseline at 4-week, and change from baseline at 12-week)
  • Kinesiophobia change(Baseline, change from baseline at 4-week, and change from baseline at 12-week)
  • Strength change(Baseline, change from baseline at 4-week, and change from baseline at 12-week)

Study Sites (1)

Loading locations...

Similar Trials